A Study to Evaluate the Safety and Clinical Performance of a Dexpanthenol Medicated Hydrogel Patch in the Treatment of Standardized Superficial Abrasions

Inclusion Criteria: * Healthy male or female volunteers aged 18 to 64 years (inclusive). * Informed consent form signed voluntarily before any study-related procedure. * Subjects willing and able to comply with all study protocol requirements, including scheduled visits and home-wear restrictions. * Intact, healthy skin on both volar forearms (free of tattoos, scars, sunburns, or active skin lesions in the designated test areas). * Agree to take precautions to prevent pregnancy (applicable only to non-menopausal women), including abstinence, intrauterine devices (IUDs), progestogen implants, combined estrogenic-progestogen contraceptives, the use of condoms; Exclusion Criteria: * Known hypersensitivity or allergy to Dexpanthenol, hydrogel components, acrylic adhesives, or any component of the investigational devices. * History of keloid formation, hypertrophic scarring, or abnormal wound healing. * Active dermatological conditions (e.g., psoriasis, eczema, atopic dermatitis, active infections) on the upper extremities. * History of diabetes mellitus, peripheral vascular disease, or arterial/venous microangiopathy. * Systemic treatment with corticosteroids, immunosuppressive drugs, Anticoagulants, antiplatelet agents or cytostatic agents within 4 weeks prior to Baseline, or anticipated need during the study. * Topical treatment (steroids, retinoids, antibiotics, or moisturizers) applied to the volar forearms within 2 weeks prior to Baseline. * Active heavy smokers (more than 10 cigarettes per day) or users of nicotine-replacement therapies (nicotine alters cutaneous microcirculation and significantly impairs wound healing kinetics) * Pregnant or lactating women, or women of childbearing potential not using highly effective contraception (see inclusion criteria). * Not willing and able to comply with all study protocol requirements